title: Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
authors.affiliation: L. Milas, K. Kishi, N. Hunter, K. Mason, P. J. Tofilon, Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston.
authors.forename: L
authors.initials: L
authors.lastname: Milas
authors.forename: K
authors.initials: K
authors.lastname: Kishi
authors.forename: N
authors.initials: N
authors.lastname: Hunter
authors.forename: K
authors.initials: K
authors.lastname: Mason
authors.forename: J L
authors.initials: JL
authors.lastname: Masferrer
authors.forename: P J
authors.initials: PJ
authors.lastname: Tofilon
mesh_terms: D000818:Animals; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D005720:Gamma Rays; D007527:Isoenzymes / Q000187:drug effects*; D051379:Mice; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D011451:Prostaglandin-Endoperoxide Synthases / Q000187:drug effects*; D011720:Pyrazoles / Q000494:pharmacology*; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D012513:Sarcoma, Experimental / Q000098:blood supply / Q000188:drug therapy* / Q000532:radiotherapy*; D013449:Sulfonamides / Q000494:pharmacology*; D000096926:Benzenesulfonamides
chemical_list: D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D011451:Prostaglandin-Endoperoxide Synthases; D011720:Pyrazoles; D011838:Radiation-Sensitizing Agents; D013449:Sulfonamides; C119130:4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide; D000096926:Benzenesulfonamides